{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:18:02Z","timestamp":1788182282221,"version":"build-2803163510"},"reference-count":57,"publisher":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:p>Background: Ribosome biogenesis is involved in the progression of hepatocellular carcinoma (HCC), but the specific mechanisms and diagnostic values of ribosome biogenesis-related genes (RBRGs) in HCC remain unclear. Objectives: We aimed to explore potential therapeutic targets in HCC from RBRGs. Methods: The differentially expressed RBRGs (DE-RBRGs) were explored using publicly available bulk RNA-sequencing data. Cox regression analysis was employed to evaluate the prognostic significance of the DE?RBRGs. The optimal machine learning algorithm was selected to construct a prognostic model. The predictive performance of the model was assessed using Kaplan?Meier analysis and receiver operating characteristic (ROC) curves. Single?cell RNA?sequencing data were subsequently utilized to identify key cell populations and the corresponding DE?RBRGs. Results: Bioinformatics analyses revealed 88 DE-RBRGs, predominantly enriched in ribosome biogenesis-related functions and pathways. The univariate Cox regression identified 12 DE-RBRGs with prognostic values. Following, the optimal machine learning algorithm (StepCox [forward] + SuperPC) was selected to construct a prognostic model. Survival analysis demonstrated that patients in the low-risk group exhibited markedly prolonged lifespan relative to their high-risk counterparts. ROC curves confirmed the predictive accuracy of this prognostic model in both training and validation cohorts. These 12 DE-RBRGs were significantly associated with immune cell infiltration, tumor immune evasion and drug sensitivity. Analysis of single-cell sequencing data identified hepatocytes as central mediators of HCC pathogenesis, which was associated with high expression of two DE-RBRGs: Nucleophosmin 1 (NPM1) and Ras-Related Nuclear Protein (RAN). Conclusion: NPM1 and RAN, which are highly expressed in hepatocytes, may serve as potential therapeutic targets in HCC. Their established roles in ribosome biogenesis could drive the development of novel therapies targeting this pathway.<\/jats:p>","DOI":"10.36721\/pjps.2026.39.7.187.1","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:13:41Z","timestamp":1779358421000},"source":"Crossref","is-referenced-by-count":0,"title":["Integrated Analysis Of Single-Cell And Bulk-RNA Sequencing Data Reveals Drug Therapeutic Targets And Prognostic Biomarkers Related To Ribosome Biogenesis In Hepatocellular Carcinoma"],"prefix":"10.36721","author":[{"given":"Anjing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22735","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, Chak S, Naikawadi RP, Wolters PJ, Abate AR, Butte AJ and Bhattacharya M (2019). Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol., 20(2): 163-172.","DOI":"10.1038\/s41590-018-0276-y"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Brown ZJ, Tsilimigras DI, Ruff SM, Mohseni A, Kamel IR, Cloyd JM and Pawlik TM (2023). Management of hepatocellular carcinoma: A review. JAMA Surg., 158(4): 410-420.","DOI":"10.1001\/jamasurg.2022.7989"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Cao K, Wang R, Li L, Liao Y, Hu X, Li R, Liu X, Xiong XD, Wang Y and Liu X (2024). Targeting DDX11 promotes PARP inhibitor sensitivity in hepatocellular carcinoma by attenuating BRCA2-RAD51 mediated homologous recombination. Oncogene, 43(1): 35-46.","DOI":"10.1038\/s41388-023-02898-x"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Chan YT, Zhang C, Wu J, Lu P, Xu L, Yuan H, Feng Y, Chen ZS and Wang N (2024). Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. Mol Cancer, 23(1): 189.","DOI":"10.1186\/s12943-024-02101-z"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Che X, Liu M, Li D, Li Z, Guo J and Jia R (2021). RAN and YBX1 are required for cell proliferation and IL-4 expression and linked to poor prognosis in oral squamous cell carcinoma. Exp. Cell Res., 406(2): 112767.","DOI":"10.1016\/j.yexcr.2021.112767"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Chen Y, Li Y, Xiong J, Lan B, Wang X, Liu J, Lin J, Fei Z, Zheng X and Chen C (2021). Role of PRKDC in cancer initiation, progression and treatment. Cancer Cell Int., 21(1): 563.","DOI":"10.1186\/s12935-021-02229-8"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Dopazo C, S\u00f8reide K, Rangelova E, Mieog S, Carrion-Alvarez L, Diaz-Nieto R, Primavesi F and St\u00e4ttner S (2024). Hepatocellular carcinoma. Eur. J. Surg. Oncol., 50(1): 107313.","DOI":"10.1016\/j.ejso.2023.107313"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Elhamamsy AR, Metge BJ, Alsheikh HA, Shevde LA and Samant RS (2022). Ribosome biogenesis: A central player in cancer metastasis and therapeutic resistance. Cancer Res., 82(13): 2344-2353.","DOI":"10.1158\/0008-5472.CAN-21-4087"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Elsalahaty MI, Salama AF, Diab T, Ghazy M, Toraih E and Elshazli RM (2023). Unleash multifunctional role of miRNA biogenesis gene variants (XPO5*rs34324334 and RAN*rs14035) with susceptibility to hepatocellular carcinoma. J. Pers. Med., 13(6): 959.","DOI":"10.3390\/jpm13060959"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Falini B (2023). NPM1-mutated acute myeloid leukemia: New pathogenetic and therapeutic insights and open questions. Am. J. Hematol., 98(9): 1452-1464.","DOI":"10.1002\/ajh.26989"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Grinchuk OV, Yenamandra SP, Iyer R, Singh M, Lee HK, Lim KH, Chow PK and Kuznetsov VA (2018). Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma. Mol. Oncol., 12(1): 89-113.","DOI":"10.1002\/1878-0261.12153"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Gu W, Sun L, Wang J and Chen X (2022). The oncogenic role of treacle ribosome biogenesis factor 1 (TCOF1) in human tumors: A pan-cancer analysis. Aging (Albany NY), 14(2): 943-960.","DOI":"10.18632\/aging.203852"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Guo S, Nguyen L and Ranum LPW (2022). RAN proteins in neurodegenerative disease: Repeating themes and unifying therapeutic strategies. Curr. Opin. Neurobiol., 72: 160-170.","DOI":"10.1016\/j.conb.2021.11.001"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Hai L, Bai XY, Luo X, Liu SW, Ma ZM, Ma LN and Ding XC (2024). Prognostic modeling of hepatocellular carcinoma based on T-cell proliferation regulators: A bioinformatics approach. Front. Immunol., 15: 1444091.","DOI":"10.3389\/fimmu.2024.1444091"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Ji X, Yang Z, Li C, Zhu S, Zhang Y, Xue F, Sun S, Fu T, Ding C, Liu Y and Wan Q (2024). Mitochondrial ribosomal protein L12 potentiates hepatocellular carcinoma by regulating mitochondrial biogenesis and metabolic reprogramming. Metabolism, 152: 155761.","DOI":"10.1016\/j.metabol.2023.155761"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Jiaze Y, Sinan H, Minjie Y, Yongjie Z, Nan D, Liangwen W, Wen Z, Jianjun L and Zhiping Y (2022). Rcl1 suppresses tumor progression of hepatocellular carcinoma: A comprehensive analysis of bioinformatics and in-vitro experiments. Cancer Cell Int., 22(1): 114.","DOI":"10.1186\/s12935-022-02533-x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Kim J, Huang K, Vo PTT, Miao T, Correia J, Kumar A, Simons MJP and Bai H (2024). Peroxisomal import stress activates integrated stress response and inhibits ribosome biogenesis. PNAS Nexus, 3(10): 429.","DOI":"10.1093\/pnasnexus\/pgae429"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Ko E, Kim JS, Ju S, Seo HW, Chang Y, Kang JA, Park SG and Jung G (2018). Oxidatively modified protein-disulfide isomerase-associated 3 promotes dyskerin pseudouridine synthase 1-mediated malignancy and survival of hepatocellular carcinoma cells. Hepatology, 68(5): 1851-1864.","DOI":"10.1002\/hep.30039"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Li Y, Jiang M, Wei Y, He X, Li G, Lu C and Ge D (2024). Integrative analyses of pyrimidine salvage pathway-related genes revealing the associations between UPP1 and tumor microenvironment. J. Inflamm. Res., 17: 101-119.","DOI":"10.2147\/JIR.S440295"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Liu H, Zhang W, Zhang Y, Adegboro AA, Fasoranti DO, Dai L, Pan Z, Liu H, Xiong Y, Li W, Peng K, Wanggou S and Li X (2024). Mime: A flexible machine-learning framework to construct and visualize models for clinical characteristics prediction and feature selection. Comput. Struct. Biotechnol. J., 23: 2798-2810.","DOI":"10.1016\/j.csbj.2024.06.035"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Liu J, Geng W, Sun H, Liu C, Huang F, Cao J, Xia L, Zhao H, Zhai J, Li Q, Zhang X, Kuang M, Shen S, Xia Q, Wong VW and Yu J (2022). Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma. Gut., 71(6): 1203-1213.","DOI":"10.1136\/gutjnl-2021-325189"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Liu TT, Li R, Huo C, Li JP, Yao J, Ji XL and Qu YQ (2021a). Identification of CDK2-related immune forecast model and ceRNA in lung adenocarcinoma, a pan-cancer analysis. Front Cell Dev. Biol., 9: 682002.","DOI":"10.3389\/fcell.2021.682002"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Liu X, Liu D, Qian D, Dai J, An Y, Jiang S, Stanley B, Yang J, Wang B, Liu X and Liu DX (2012). Nucleophosmin (NPM1\/B23) interacts with activating transcription factor 5 (ATF5) protein and promotes proteasome- and caspase-dependent ATF5 degradation in hepatocellular carcinoma cells. J. Biol. Chem., 287(23): 19599-609.","DOI":"10.1074\/jbc.M112.363622"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Liu Z, Pang Y, Jia Y, Qin Q, Wang R, Li W, Jing J, Liu H and Liu S (2021b). SNORA23 inhibits HCC tumorigenesis by impairing the 2'-O-ribose methylation level of 28S rRNA. Cancer Biol. Med., 19(1): 104-19.","DOI":"10.20892\/j.issn.2095-3941.2020.0343"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Love MI, Huber W and Anders S (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 15(12): 550.","DOI":"10.1186\/s13059-014-0550-8"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Luo Y, Lin J, Zhang Y, Dai G, Li A and Liu X (2020). LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis. Cell Biochem. Funct., 38(7): 895-904.","DOI":"10.1002\/cbf.3510"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Nault JC, De Reyni\u00e8s A, Villanueva A, Calderaro J, Rebouissou S, Couchy G, Decaens T, Franco D, Imbeaud S, Rousseau F, Azoulay D, Saric J, Blanc JF, Balabaud C, Bioulac-Sage P, Laurent A, Laurent-Puig P, Llovet JM and Zucman-Rossi J (2013). A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection. Gastroenterology, 145(1): 176-187.","DOI":"10.1053\/j.gastro.2013.03.051"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Neueder A and Bates GP (2018). RNA Related Pathology in Huntington's Disease. Adv. Exp. Med. Biol., 1049: 85-101.","DOI":"10.1007\/978-3-319-71779-1_4"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Ni C and Buszczak M (2023). Ribosome biogenesis and function in development and disease. Development, 150(5): dev201187.","DOI":"10.1242\/dev.201187"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Pan Y, Zhu Q, Hong T, Cheng J and Tang X (2024). Targeting PRKDC activates the efficacy of antitumor immunity while sensitizing to chemotherapy and targeted therapy in liver hepatocellular carcinoma. Aging (Albany NY), 16(10): 9047-9071.","DOI":"10.18632\/aging.205855"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Rosell-D\u00edaz M, Petit-Gay A, Molas-Prat C, Gallardo-Nuell L, Rami\u00f3-Torrent\u00e0 L, Garre-Olmo J, P\u00e9rez-Brocal V, Moya A, Jov\u00e9 M, Pamplona R, Puig J, Ramos R, B\u00e4ckhed F, Mayneris-Perxachs J and Fern\u00e1ndez-Real JM (2024). Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men. Metabolism, 157: 155941.","DOI":"10.1016\/j.metabol.2024.155941"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Roy SK, Srivastava S, Mccance C, Shrivastava A, Morvant J, Shankar S and Srivastava RK (2024). Clinical significance of PNO1 as a novel biomarker and therapeutic target of hepatocellular carcinoma. J. Cell Mol. Med., 28(9): e18295.","DOI":"10.1111\/jcmm.18295"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Saffarian S, Cai Z, Lam J, Oo HZ and Somasekharan S (2025). Elevated NPM1 and FBL expression correlates with prostate cancer aggressiveness and progression. J. Pathol, 267(1): 56-68.","DOI":"10.1002\/path.6447"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Su SG, Li QL, Zhang MF, Zhang PW, Shen H and Zhang CZ (2020). An E2F1\/DDX11\/EZH2 positive feedback loop promotes cell proliferation in hepatocellular carcinoma. Front Oncol., 10: 593293.","DOI":"10.3389\/fonc.2020.593293"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A and Bork P (2016). The STRING database in 2017: Quality-controlled protein\u2013protein association networks, made broadly accessible. Nucleic acids research, 45(D1): D362-D368.","DOI":"10.1093\/nar\/gkw937"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Tseng YJ, Krans A, Malik I, Deng X, Yildirim E, Ovunc S, Tank EMH, Jansen-West K, Kaufhold R, Gomez NB, Sher R, Petrucelli L, Barmada SJ and Todd PK (2024). Ribosomal quality control factors inhibit repeat-associated non-AUG translation from GC-rich repeats. Nucleic. Acids Res., 52(10): 5928-5949.","DOI":"10.1093\/nar\/gkae137"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Wang D, Yang Q, Zhu G, Li Z, Wu C, Hu X, Long G, Wang Q, Chen Y, Xu C, Huang C, Han Y and Zhang D (2025). Voxtalisib inhibits enterovirus 71 replication by downregulating host RAN and restoring IFN-STAT signaling. J. Adv. Res., 81: 569-582.","DOI":"10.1016\/j.jare.2025.05.053"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Wang P, Wang M, Liu L, Li H, Liu H, Ren J, Liu T, Cong M, Zhu Z, Zhao X, Sun L and Jia J (2024a). Targeting NPM1 inhibits proliferation and promotes apoptosis of hepatic progenitor cells via suppression of mTOR signalling pathway. Stem. Cell Res. Ther., 15(1): 292.","DOI":"10.1186\/s13287-024-03898-8"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Wang X, Zhang XY, Liao NQ, He ZH and Chen QF (2024b). Identification of ribosome biogenesis genes and subgroups in ischaemic stroke. Front Immunol., 15: 1449158.","DOI":"10.3389\/fimmu.2024.1449158"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Wang Y and Deng B (2023). Hepatocellular carcinoma: Molecular mechanism, targeted therapy and biomarkers. Cancer Metastasis Rev., 42(3): 629-652.","DOI":"10.1007\/s10555-023-10084-4"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F and Lopes CT (2010). The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function. Nucleic. acids research, 38: W214-W220.","DOI":"10.1093\/nar\/gkq537"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Wei C, Wang B, Chen ZH, Xiao H, Tang L, Guan JF, Yuan RF, Yu X, Hu ZG, Wu HJ, Dai Z and Wang K (2022). Validating RRP12 expression and its prognostic significance in hcc based on data mining and bioinformatics methods. Front Oncol., 12: 812009.","DOI":"10.3389\/fonc.2022.812009"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Wu B, Liu DA, Guan L, Myint PK, Chin L, Dang H, Xu Y, Ren J, Li T, Yu Z, Jabban S, Mills GB, Nukpezah J, Chen YH, Furth EE, Gimotty PA, Wells RG, Weaver VM, Radhakrishnan R, Wang XW and Guo W (2023). Stiff matrix induces exosome secretion to promote tumour growth. Nat. Cell Biol., 25(3): 415-424.","DOI":"10.1038\/s41556-023-01092-1"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Wu C, Xia D, Wang D, Wang S, Sun Z, Xu B and Zhang D (2022). TCOF1 coordinates oncogenic activation and rRNA production and promotes tumorigenesis in HCC. Cancer Sci., 113(2): 553-564.","DOI":"10.1111\/cas.15242"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, Fu X, Liu S, Bo X and Yu G (2021). ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb), 2(3): 100141.","DOI":"10.1016\/j.xinn.2021.100141"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Xiao B, Liu L, Li A, Xiang C, Wang P, Li H and Xiao T (2020). Identification and verification of immune-related gene prognostic signature based on ssGSEA for osteosarcoma. Front Oncol., 10: 607622.","DOI":"10.3389\/fonc.2020.607622"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Yang XM, Wang XQ, Hu LP, Feng MX, Zhou YQ, Li DX, Li J, Miao XC, Zhang YL, Yao LL, Nie HZ, Huang S, Xia Q, Zhang XL, Jiang SH and Zhang ZG (2023). Nucleolar HEAT repeat containing 1 up-regulated by the mechanistic target of rapamycin complex 1 signaling promotes hepatocellular carcinoma growth by dominating ribosome biogenesis and proteome homeostasis. Gastroenterology, 165(3): 629-646.","DOI":"10.1053\/j.gastro.2023.05.029"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Yu G, Xu S, Kong J, He J and Liu J (2023a). Development and validation of web calculators to predict early recurrence and long-term survival in patients with duodenal papilla carcinoma after pancreaticoduodenectomy. BMC Cancer, 23(1): 1129.","DOI":"10.1186\/s12885-023-11632-5"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Yu J, Ling S, Hong J, Zhang L, Zhou W, Yin L, Xu S, Que Q, Wu Y, Zhan Q, Bao J, Xu N, Liu Y, Chen K, Wei X, Liu Z, Feng T, Zhou L, Xie H, Wang S, Liu J, Zheng S and Xu X (2023b). TP53\/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma. J. Immunother. Cancer, 11(11): e007479.","DOI":"10.1136\/jitc-2023-007479"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Zang Y, Ran X, Yuan J, Wu H, Wang Y, Li H, Teng H and Sun Z (2024). Genomic hallmarks and therapeutic targets of ribosome biogenesis in cancer. Brief Bioinform, 25(2): 1-13.","DOI":"10.1093\/bib\/bbae023"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Zhang D, Wu F, Song J, Meng M, Fan X, Lu C, Weng Q, Fang S, Zheng L, Tang B, Yang Y, Tu J, Xu M, Zhao Z and Ji J (2022). A role for the NPM1\/PTPN14\/YAP axis in mediating hypoxia-induced chemoresistance to sorafenib in hepatocellular carcinoma. Cancer Cell Int., 22(1): 65.","DOI":"10.1186\/s12935-022-02479-0"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Zhang Q, Liu X, Zou Z and Zhou B (2023a). Evidence from a meta-analysis for the prognostic and clinicopathological importance of DKC1 in malignancies. Future Oncol., 19(6): 473-484.","DOI":"10.2217\/fon-2022-1125"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Zhang S, Li X, Zheng Y, Liu J, Hu H, Zhang S and Kuang W (2023b). Single cell and bulk transcriptome analysis identified oxidative stress response-related features of Hepatocellular carcinoma. Front Cell Dev. Biol., 11: 1191074.","DOI":"10.3389\/fcell.2023.1191074"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Zhao S, Zhang D, Liu S and Huang J (2023). The roles of NOP56 in cancer and SCA36. Pathol. Oncol. Res., 29: 1610884.","DOI":"10.3389\/pore.2023.1610884"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Zhou W, Chen Y, Luo R, Li Z, Jiang G and Ou X (2021). Identification of biomarkers related to immune cell infiltration in hepatocellular carcinoma using gene co-expression network. Pathol. Oncol. Res., 27: 601693.","DOI":"10.3389\/pore.2021.601693"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Zhou W, Lin L, Chen D, Wang J and Chen J (2024). Construction of a liver cancer prognostic model based on interferon-gamma-related genes for revealing the immune landscape. J. Environ. Pathol. Toxicol. Oncol., 43(4): 25-42.","DOI":"10.1615\/JEnvironPatholToxicolOncol.2024049848"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Zhu J, Wang H and Jiang X (2022). mTORC1 beyond anabolic metabolism: Regulation of cell death. J. Cell Biol., 221(12): e202208103.","DOI":"10.1083\/jcb.202208103"}],"container-title":["Pakistan Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:31:03Z","timestamp":1788179463000},"score":1,"resource":{"primary":{"URL":"https:\/\/pjps.pk\/single-article?id=7790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":57,"URL":"https:\/\/doi.org\/10.36721\/pjps.2026.39.7.187.1","relation":{},"ISSN":["1011-601X","3105-9686"],"issn-type":[{"value":"1011-601X","type":"print"},{"value":"3105-9686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]}}}